Best known for his seminal research that led to the elucidation of oncogenes, Dr. Vogt’s genetic studies contributed critically to the identification of the first oncogene src and to the discovery that retroviral oncogenes are derived from the genome of the cell. His contributions include the identification of additional retroviral oncogenes that have become important in human cancer such as myc, jun and PI3-kinase. Today PI3-kinase is considered one of the most promising cancer targets.
Dr. Vogt’s recent research on cancer-specific mutations in p110 has shown that these mutations confer oncogenic activity, making them highly specific targets. He also continues work on small molecule inhibitors of the Myc protein, challenging the dogma that Myc is undruggable. Besides an active research program, he maintains a long-standing interest in painting and is a skilled water colorist.
2017 Prize for Scientific Excellence in Medicine, American Italian Cancer Foundation
2016 IHV Lifetime Achievement Award for Scientific Contributions
2013 Pezcoller Foundation-AACR International Award for Cancer Research
2013 Einstein Professorship awarded by Chinese Academy of Sciences
2010 Albert Szent-Györgyi Prize for Progress in Cancer Research
2010 Loeffler-Frosch Medal, German Society of Virology
2008 Gregor Johann Mendel Medal, National Academy of Sciences of the Czech Republic
2004 Elected Fellow, American Academy of Arts and Sciences
2003 Elected Member, Institute of Medicine
1998 Elected Member, German National Academy of Sciences
1991 Elected Member, American Philosophical Society
1991 Charles S. Mott Prize, General Motors Cancer Research Foundation
1989 Bristol Myers Squibb Award
1987 Robert J. and Claire Pasarow Award
1985 Ernst Jung Prize for Medicine
1980 Elected Member, National Academy of Sciences, Washington, D.C.
1976 Irene-Vogeler Prize, Max Planck Society
1959 PhD, University of Tubingen, Germany